Serum Institute of India will manufacture the Gates MRI-backed M72/AS01E TB vaccine candidate, which could become the first ...

Serum Institute partners with Gates MRI to manufacture new TB vaccine candidate: Our Bureau, Mumbai Friday, July 17, 2026, 15:10 Hrs [IST] The Gates Medical Research Institute (Ga ...

Tuberculosis remains world’s deadliest infectious disease despite being preventable and curable. Around 1.23 million of 10.7 ...

The Gates Medical Research Institute (Gates MRI) has signed a landmark agreement with the Serum Institute of India Private Limited (SII) to manufacture M72/AS01E ...

India’s growing protein gap is fuelling a boom in protein supplements, but are Indians getting enough nutrition from ...

Measles is making a worrying comeback across the globe, with outbreaks now reported in every WHO region. New surveillance ...

India's Serum Institute of India (SII) has announced that it will manufacture an experimental tuberculosis (TB) vaccine under ...

A new TB vaccine could be the biggest breakthrough in over 100 years. The Serum Institute of India (SII) will manufacture the ...

Serum Institute of India (SII) has entered into an agreement with the Gates Medical Research Institute (Gates MRI) to develop ...

The novel vaccine candidate, M72/AS01E, has been in development for two decades and is currently in a late-stage clinical trial.

Gates Medical Research Institute and Serum Institute of India have partnered to manufacture M72/AS01E, a novel tuberculosis vaccine undergoing Phase III clinical trials.

The Gates Medical Research Institute (Gates MRI) has signed an agreement with Pune-based Serum Institute of India Private Limited (SII) to manufactur ...